Marco Zaramella
- Immunology top 10%
- Hepatology top 2%
- Epidemiology top 10%
- Infectious Diseases
- Rheumatology
- Co-authors
- Mario U. MondelliG MicheloneStefania VarchettaBarbara OlivieroFrancesca FilippiSavino BrunoDomenico MavilioSerena Ludovisi
- Topics
- Hepatitis C virus research (5 papers)Hepatitis B Virus Studies (2 papers)Venous Thromboembolism Diagnosis and Management (2 papers)
- Cited by
- HepatologyImmunologyEpidemiology
- Journals
- SHILAP Revista de lepidopterologíaGastroenterologyJournal of Hepatology
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Marco Zaramella
11 papers receiving 554 citations
Peers
Comparison fields: 5 of 59
- Immunology 317
- Hepatology 296
- Epidemiology 284
- Infectious Diseases 51
- Rheumatology 48
Countries citing papers authored by Marco Zaramella
This map shows the geographic impact of Marco Zaramella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Zaramella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Zaramella more than expected).
Fields of papers citing papers by Marco Zaramella
This network shows the impact of papers produced by Marco Zaramella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Zaramella. The network helps show where Marco Zaramella may publish in the future.
Co-authorship network of co-authors of Marco Zaramella
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Zaramella. A scholar is included among the top collaborators of Marco Zaramella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Zaramella. Marco Zaramella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 7 | |
| 3 | Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study. | 2 |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 58 | |
| 7 | 128 | |
| 8 | 335 | |
| 9 | Defective cytotoxic function of intrahepatic natural killer cells in chronic hepatitis C virus infection | 1 |
| 10 | 1 | |
| 11 | 19 |
About Marco Zaramella
Marco Zaramella is a scholar working on Hepatology, Internal Medicine and Applied Microbiology and Biotechnology, having authored 11 papers that have together received 562 indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Hepatology (296 citations), Immunology (317 citations) and Epidemiology (284 citations). Marco Zaramella has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Mario U. Mondelli, G Michelone, Stefania Varchetta, Barbara Oliviero, Francesca Filippi, Savino Bruno, Domenico Mavilio, Serena Ludovisi, Somnath S. Pai and Antonella Cerino. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.